Nov. 4–8, 2026 | Phoenix Convention Center in Phoenix, AZ | #SITC26

I'm Interested

Advance the science, discover breakthroughs and educate the world on cancer immunotherapy.

Researchers

Share your latest research with cancer immunotherapy leaders.

Clinicians

Learn how the latest immuno-oncology science can better treat your patients.

Industry

Network with international leaders from academia and government.

Early Career Scientists

Meet established leaders in the cancer immunotherapy field.

Get the latest SITC 2026 updates

Thank you for your interest in our SITC 2026 Annual Meeting in Phoenix, AZ from Nov. 4–8, 2026 at the Phoenix Convention Center. Sign up to get the latest SITC 2026 information on registration, abstracts, sponsorship and exhibiting opportunities.

An Invitation to Exhibit at SITC 2026

Advancing the Science and Application of Cancer Immunotherapy Worldwide

Make your mark at the largest cancer immunotherapy conference and exhibit at SITC 2026, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC. At SITC’s Annual Meeting, we will bring together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.

If you have a product or service that will advance research or accelerate laboratory results, do not miss this opportunity to exhibit at SITC 2026.

Reservations for returning 2025 exhibitors will open March 2026. New exhibitors can begin applying in May. Contact development@sitcancer.org to receive the most up to date information. Dates subject to change.

Exhibit Hall

WHO EXHIBITS AT SITC?

Biotechnology companies, cancer organizations/foundations, consulting groups, data management companies, informatics/analysis firms, medical device manufacturers, medical equipment suppliers, medical publishers, pharmaceutical companies, research companies/agencies, scientific supply companies, universities/hospitals/research institutions.

Exhibit Hall Group

HYBRID EXHIBITS

Each face-to-face exhibit booth includes an optional virtual booth space to connect with registrants who cannot attend in person. Take advantage of this space to network with attendees, feature resources and publications, highlight posters and symposia, and link to your company website.

Exhibit Hall Group

GET IN TOUCH

Contact our Development Team to learn more about exhibiting and/or sponsorship opportunities at SITC 2026. Please email us at development@sitcancer.org and we will be in touch as soon as possible. We hope to see you in Phoenix! 

Why Attend SITC 2026?

SITC 2026 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy.

Cutting-edge sessions by IO experts 

Don't miss over 40 sessions on the latest IO research

In-person networking opportunities with IO luminaries

Structured and informal discussions, including important networking opportunities with basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers

Access the latest immuno-oncology research

Browse over 1200 abstracts, explore hundreds of poster presentations and hear from leading researchers during oral presentations

Find out what SITC can do for you.

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

Our mission is to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field.

We aim to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Become a Member